Ligand validation:3UKO

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3UKO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UKO_NAD_B_402	97%	31%	0.063	0.981	1.44	1.41	8	8	2	0	100%	1
3UKO_NAD_A_402	93%	38%	0.077	0.971	1.09	1.38	4	6	1	0	100%	1
4JJI_NAD_B_403	95%	32%	0.068	0.973	1.17	1.64	4	10	0	0	100%	1
4L0Q_NAD_A_403	92%	30%	0.078	0.967	1.04	1.88	2	15	1	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.